News

BlogsPosts
Event
2019 EBD Biotech Showcase
RepliCel is excited to have been chosen to present at next year's EBD Biotech Showcase
BlogsPosts
Event
2018 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings.
BlogsPosts
Event
2017 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings.
BlogsPosts
Event
2016 EBD Biotech Showcase
RepliCel presented and conducted one-on-one partnering meetings.
BlogsPosts
Event
RepliCel Executives to Present at 9th World Congress for Hair Research in Miami
Conference brings together hair biologists, dermatologists, cosmetic scientists and leading biotech companies to discuss the
BlogsPosts
Event
RepliCel Selected as One of This Year’s Top 20 Public Canadian Technology Companies
Canadian Innovation Exchange (CIX) Public Investor Day November 18 at Toronto’s MaRS Discovery District to
BlogsPosts
Event
RepliCel Announces October Presentation and Partnering Meeting Schedule
VANCOUVER, BC – October 8, 2015 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSX.V: RP),
BlogsPosts
Event
RepliCel Presenting at Two Upcoming Investment and Partnering Forums
A Chinese-based investor forum in Toronto and an aesthetics & dermatology conference in Newport Beach
BlogsPosts
Event
RepliCel Presenting at InvestMNT Investor Conference in Minneapolis
Conference attracts investment professionals in the Twin Cities area
BlogsPosts
Event
RepliCel Life Sciences Announces Participation in 23rd World Congress of Dermatology, Vancouver, BC
Conference program to include presentations on the clinical development of RepliCel’s skin rejuvenation, hair regeneration,
BlogsPosts
Event
RepliCel to Present Unique Autologous Cell Treatment for Achilles Tendinosis at International Society for Cellular Therapy Conference
Clinical trial at the University of British Columbia now recruiting patients
BlogsPosts
Press Release Event
RepliCel Life Sciences Selected to Present at Cavendish Global Health Impact Forum
Unique forum brings together leading family offices and foundations seeking impactful investment and philanthropic opportunities
BlogsPosts
Event
RepliCel Life Sciences to Present at 11th Annual Phacilitate Cell & Gene Therapy Forum in Washington, DC
VANCOUVER, BC – January 20, 2015 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),
BlogsPosts
Event
RepliCel Life Sciences to Present at Biotech Showcase 2015
Meetings focused on investors, analysts, and potential partners for RCS-01 and RCT-01 cell therapies VANCOUVER, BC
BlogsPosts
Event
RepliCel Life Sciences to Present at World Stem Cell Summit 2014
Over multiple sessions, Lee Buckler will present a RepliCel update, participate in session panels, and
BlogsPosts
Event
RepliCel to Present Commercial and Clinical Update at BioJapan 2014 World Business Forum
Japanese meetings to focus on partnering VANCOUVER, BC
BlogsPosts
Event
RepliCel to Present Clinical Trial Update at Stem Cell Meeting on the Mesa Partnering Forum in California
VANCOUVER, BC – October 2, 2014 – RepliCel Life Sciences Inc. (TSX.V: RP) (OTCQB: REPCF),
BlogsPosts
Event
RepliCel to Present at Rodman & Renshaw’s 16th Annual Global Investment Conference in New York
VANCOUVER, BC – September 4, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP),
BlogsPosts
Event
RepliCel to Present RCH-01 Phase 1 Clinical Data at the 13th Congress of the Japanese Society for Regenerative Medicine
VANCOUVER, BC – February 27, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (TSXV: RP)
BlogsPosts
Event
RepliCel Life Sciences to Present at Biotech Showcase™ 2014
Vancouver, Canada – January 9, 2014 – RepliCel Life Sciences Inc. (OTCQB: REPCF) (CSE: RP),

DISCLAIMER:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, RepliCel Life Sciences Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.

THIRD PARTY CONTENT
Please note that any opinion, estimates or forecasts made by the authors of these statements are theirs alone and do not represent opinions, forecasts or predictions of RepliCel Life Sciences Inc. or its management. RepliCel Life Sciences Inc. does not, by its reference or distribution of these links imply its endorsement of, or concurrence with, such information, conclusions or recommendations.